Navigation Links
Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
Date:10/5/2007

- Presentation to highlight milestones including phase III development of

'GI-friendly' NSAIDs for mild to moderate pain -

PALO ALTO, Calif., Oct. 5 /PRNewswire/ --

What: Horizon Therapeutics, Inc. is pleased to announce that

George Tidmarsh, M.D., Ph.D., chief executive officer, will

showcase Horizon's corporate and clinical milestones,

including its recent completion of Series C financing, and

provide an update on the development of the Company's

product pipeline during an Open House Podium Presentation

at BioPartnering Europe (BPE). Immediately following the

presentation Dr. Tidmarsh will be available to field

questions and provide more detailed information on Horizon

Therapeutics.

BPE was first held in London in 1993 as a partnership

between the U.S. Commercial Service and Technology Vision

Group LLC to bring about closer ties between American and

European biotechnology companies. From the beginning, BPE

has attracted the support of leading pharmaceutical,

biotechnology, financial and service companies that have

all contributed to making BPE one of the leading

independent partnering events in the world. BPE has a high

rate of sponsor retention, which indicates its prominent

position on the annual conference calendar for many

industry leaders.

When: Monday, October 8, 2007

9:30 a.m. - 12:45 p.m. Open House Podium Presentation

(10:45-10:55 a.m. Horizon presentation)

Where: London, England

QEII Conference Centre

Abbey Room West - Stream 1

Spokespeople: George Tidmarsh, M.D., Ph.D., co-founder and CEO of Horizon

Therapeutics

Barry Golombik, co-founder of Horizon Therapeutics

Contact: Julie Normart

WeissComm Partners

415.946.1087

jnormart@weisscommpartners.com

About Horizon Therapeutics:

Horizon Therapeutics, Inc. is a late stage biopharmaceutical company focused on the rapid development and commercialization of therapeutic treatments for mild-to-moderate pain management. The Company is building a novel portfolio of therapies through innovative combinations of approved pharmaceutical products that seek to improve safety, efficacy, and patient compliance. Its lead product candidate, HZT-501, entered Phase 3 trials in 2007. In addition to HZT-501, Horizon has a pipeline of follow-on pain combination products in earlier stages of development. For more information visit http://www.horizontherapeutics.com.


'/>"/>
SOURCE Horizon Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. New hope on the Horizon for People Wishing to Quit Smoking
2. A new horizon
3. Conjoined Indian Twins See Hope On The Horizon
4. Stem cell cure for peripheral vascular disease: New hope on the horizon
5. Oral Flu Vaccine On The Horizon In Russia
6. Rescheduled: Aerial Mosquito Treatment for Philadelphia
7. First Keyhole Heart Valve Surgery Scheduled in Britain
8. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
9. Researchers Present Ways To Reduce The Risk Of Dementia
10. Researchers Present Data Regarding The Efficiency Of Herbs
11. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... ... November 12, 2019 , ... ... study. With increasing site activation cycle times, extended contract negotiations and 80 percent ... an area of clinical operations that’s ripe for improvement. Following an overview of ...
(Date:11/11/2019)... IRVINE, Calif. (PRWEB) , ... November 11, 2019 ... ... providers of business support services to dental groups in the United States, today ... serving the community of Lodi, CA. , Patients will enjoy convenient hours, comfortable ...
(Date:11/11/2019)... ... 11, 2019 , ... Dr. John V. Prunskis, co-founder and co-Medical Director of ... Pain Management Best Practices Task Force (Pain Task Force) met last Monday with Joe ... to the HHS Pain Task Force’s final report that was submitted to Congress in ...
(Date:11/9/2019)... YORK (PRWEB) , ... November 09, 2019 , ... On ... the story of a retired and disabled 64-year-old New Yorker who recently faced homelessness. ... moved her into transitional housing until she found a new home in an assisted-living ...
(Date:11/7/2019)... ... 07, 2019 , ... Understanding UDI in EU Device Regulations, An FDAnews Webinar, ... Are EU device and IV diagnostics sales in jeopardy? , It’s not a trick ... ahead, and many device and diagnostics makers simply aren’t prepared. , Not yet anyway. ...
Breaking Medicine News(10 mins):
(Date:11/11/2019)... , ... November 11, 2019 , ... Over 60 schools ... telehealth service in place. The program is designed to provide virtual mental health care ... storm that struck the region in October of 2018 [1]. , “This initiative by ...
(Date:11/11/2019)... , ... November 11, 2019 , ... The Naderi Center ... America health care practice POS, point of sale, website for providing the highest level ... Naderi Center for Cosmetic Surgery Specialists uses advanced financial technology in their daily business ...
(Date:11/11/2019)... ... ... The Advocator Group, LLC, part of Brown & Brown Inc., is honored ... the Boston Globe Magazine. This recognition has been earned for the fourth consecutive year ... , The rankings for the Top 100 Women-Led Businesses in each state are ...
Breaking Medicine Technology: